Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral
The VA rates Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral under Diagnostic Code 5279 at a single 10% level. With a cap of 10%, most veterans pursue secondary conditions to increase their combined rating.
Rating schedule — DC 5279 at a glance
- Minimum rating
- 10%
- Maximum rating
- 10%
- Rating tiers
- 1
- CFR section
- § 4.71a
- Body system
- Musculoskeletal System
- Secondary conditions
- 0
Lowest schedular rating available
TDIU may raise effective compensation to 100%
10%
Part 4 rating schedule
None mapped
What are the VA rating criteria for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral?
| Rating | Criteria |
|---|---|
| 10% | Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral |
“Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral”
Common Questions About Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral VA Ratings
What is the VA rating range for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral?
The VA rates Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral under Diagnostic Code 5279 at 10%. The minimum 10% rating requires: Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral. The maximum 10% rating requires: Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral.
Which 38 CFR diagnostic code does the VA use for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral?
The VA rates Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral under Diagnostic Code (DC) 5279, governed by 38 CFR 38 CFR § 4.71a. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
Can Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral qualify for TDIU?
Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral maxes at 10%, well below the single-disability TDIU threshold. However, combined with other service-connected disabilities, TDIU may be achievable under 38 CFR § 4.16. Focus on establishing secondary conditions to increase the combined rating.
What evidence supports a higher rating for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral?
The key evidence for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral is documentation of how the condition affects daily functioning. For musculoskeletal conditions, range of motion measurements (active, passive, weight-bearing, and non-weight-bearing per Correia v. McDonald) and flare-up documentation are critical. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.
What happens at the C&P exam for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral?
The C&P examiner uses a Musculoskeletal System DBQ and evaluates your condition against the DC 5279 rating criteria. Expect range of motion testing in multiple positions. Under Correia v. McDonald, the examiner must test active, passive, weight-bearing, and non-weight-bearing range of motion. Report your worst flare-up symptoms — if you cannot attend during a flare, request the exam be rescheduled.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits